false--12-310000019612Depositary Shares 0000019612 2020-10-23 2020-10-23 0000019612 tcf:DepositarySharesMember 2020-10-23 2020-10-23 0000019612 us-gaap:CommonStockMember 2020-10-23 2020-10-23


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

 FORM 8-K
 
 CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):
October 23, 2020
TCFCORPORATELOGO2020.JPG

 TCF FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)
Michigan
000-08185
38-2022454
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
333 W. Fort Street, Suite 1800, Detroit, Michigan 48226
(Address of principal executive offices, including Zip Code)
 
(800) 867-9757
(Registrant’s telephone number, including area code)
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
(Title of each class)
(Trading Symbol(s))
(Name of exchange on which registered)
Common Stock (par value $1 per share)
TCF
The NASDAQ Stock Market
Depositary shares, each representing a 1/1000th interest in a share of the 5.70% Series C Non-Cumulative
Perpetual Preferred Stock
TCFCP
The NASDAQ Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨







Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 26, 2020, TCF Financial Corporation (“TCF” or the “Company”) announced that Craig R. Dahl, Chief Executive Officer and President of TCF will leave the Company on October 27, 2020. In addition, Mr. Dahl will resign from the Board of Directors of TCF (the “Board”) and TCF National Bank (“TCF Bank”), effective as of that date.

The Board elected David T. Provost, age 66, Chief Executive Officer of the Company effective as of October 28, 2020. In connection with his role as Chief Executive Officer of TCF, Mr. Provost will receive an annual salary of one dollar, subject to adjustment from time to time, and will be eligible to participate in other benefits of the Company applicable to employees. Pursuant to TCF’s compensation policy applicable to Directors, he will not be compensated for his role as a Director while he is an employee of the Company. Mr. Provost has served as our Vice Chairman since August 1, 2019, a role he also held from September 2016 to June 2017, and which he will give up upon his election as Chief Executive Officer. He also served as our Chief Executive Officer and President from June 2017 until August 2019. From 2008 until September 2016, Mr. Provost was Chief Executive Officer, President and a Director of Talmer Bancorp, Inc.

To fill the vacancy on the Board, the Board elected Thomas C. Shafer, age 62, to serve as a Director and Vice Chairman of the Board effective as of October 28, 2020. Mr. Shafer was also elected to the role of Chief Executive Officer of TCF Bank effective as of October 28, 2020. In accordance with the terms of TCF’s Director Compensation Policy, Mr. Shafer will receive no compensation for his service as a Director while he is an employee of the Company. The Board of Directors of TCF Bank also elected Michael S. Jones, currently Executive Vice President of Regional Banking, President and Chief Operating Officer of TCF Bank, effective as of October 28, 2020.

In connection with Mr. Dahl’s departure, the Company and Mr. Dahl entered into a Separation and Release Agreement (the “Separation Agreement”) effective as of October 26, 2020. Pursuant to the terms of the Separation Agreement, Mr. Dahl increased the Restricted Period contained in the Dahl Agreement (as defined below) following his employment to three years, will provide post-employment advisory services to TCF through January 29, 2021, and will receive (a) one lump sum payment of $11,213,931, less applicable withholding taxes, payable on the first payroll date after the Separation Agreement becomes enforceable, with all revocation dates having expired, and (b) payments totaling $1,500,000, less applicable withholding taxes, payable in equal monthly installments on the first day of each month for a period of eighteen months, commencing on May 1, 2021.

Mr. Dahl’s right to receive the benefits described in the Separation Agreement are, except as set forth herein, in lieu of any other compensation, including, without limitation, under Mr. Dahl’s Amended and Restated Employment Agreement with TCF, dated as of November 6, 2019 (the “Dahl Agreement”), filed as Exhibit 10(a) to the Company’s Quarterly Report on Form 10-Q, filed by the Company on November 12, 2019. Mr. Dahl’s right to receive compensation under the Separation Agreement is conditioned upon his compliance with the non-competition and non-solicitation provisions contained in the Dahl Agreement (as modified by the Separation Agreement to increase the duration to three years from two years). Mr. Dahl’s separation is a termination without cause, and his outstanding equity awards will be treated in accordance with the terms of the Dahl Agreement. The foregoing is a summary only and does not purport to be a complete description of all of the terms of the Separation Agreement, and is subject to and qualified in its entirety by reference to the full text filed herewith as Exhibit 10.1 to this Current Report on Form 8-K.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The Board of the Company approved Amended and Restated Bylaws of the Company (the “Amended Bylaws”) effective as of October 28, 2020. The changes to the Amended Bylaws (i) eliminate the supermajority voting requirements related to organizational changes at TCF Bank; (ii) reflect the organizational changes disclosed in this Current Report on Form 8-K; and (iii) provide that the next vacancy, if any, resulting from the cessation of service by any Legacy Chemical Director for any reason after October 28, 2020 and prior to the end of the Specified Period shall be filled by the Board of Directors with a nominee selected by the Legacy TCF Directors Nominating Committee.

Capitalized terms not defined in this item have the meaning ascribed to them in the Amended Bylaws. The foregoing description is qualified in its entirety by reference to the full text of the Amended Bylaws, a marked copy showing the changes of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.






Item 8.01 Other Events.

On October 26, 2020, the Company issued a press release regarding changes in its Board membership and executive leadership. A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.
 
(d)         Exhibits.







SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
TCF FINANCIAL CORPORATION
 
 
 
 
 
/s/ Craig R. Dahl
 
Craig R. Dahl, 
President and Chief Executive Officer  
(Principal Executive Officer)
 
 
 
 
 
/s/ Brian W. Maass
 
Brian W. Maass, 
Executive Vice President and Chief Financial Officer 
(Principal Financial Officer)
 
 
 
 
 
/s/ Kathleen S. Wendt
 
Kathleen S. Wendt, 
Executive Vice President and Chief Accounting Officer 
(Principal Accounting Officer)
 
Dated:  October 26, 2020





Exhibit 3.1

AMENDED AND RESTATED BYLAWS

OF

TCF FINANCIAL CORPORATION
(Effective as of October 28, 2020)


ARTICLE I
OFFICES

1.01    PRINCIPAL OFFICE. The principal office of the corporation shall be at such place within the State of Michigan as the Board of Directors shall determine from time to time.

1.02    OTHER OFFICES. The corporation may also have offices at such other places as the Board of Directors from time to time determines or the business of the corporation requires.

ARTICLE II
SEAL

2.01    SEAL. The corporation shall have a seal in such form as the Board of Directors may from time to time determine. The seal may be used by causing it or a facsimile to be impressed, affixed, reproduced or otherwise.

ARTICLE III
CAPITAL STOCK

3.01    ISSUANCE OF SHARES. The shares of capital stock of the corporation shall be issued in such amounts, at such times, for such consideration and on such terms and conditions as the Board shall deem advisable, subject to the provisions of the Articles of Incorporation of the corporation and the further provisions of these Bylaws, and subject also to any requirements or restrictions imposed by the laws of the State of Michigan.

3.02    CERTIFICATES FOR SHARES. The shares of the corporation may be represented by certificates signed by the Chair of the Board, President or a Vice President and by the Treasurer, Assistant Treasurer, Secretary or Assistant Secretary of the corporation, and may be sealed with the seal of the corporation or a facsimile thereof. The signatures of the officers may be facsimiles if the certificate is countersigned by a transfer agent or registered by a registrar other than the corporation itself or its employee. In case an officer who has signed or whose facsimile signature has been placed upon a certificate ceases to be such officer before the certificate is issued, it may be issued by the corporation with the same effect as if he were such officer at the date of issuance. A certificate representing shares shall state upon its face that the corporation is formed under the laws of the State of Michigan; the name of the person to whom it is issued; the number and class of shares, and the designation of the series, if any, which the certificate represents; the par value of each share represented by the certificate, or a statement that the shares are without par value; and such other provisions as may be required by the laws of the State of Michigan. The Board of Directors may authorize the issuance of some or all of the shares of any class or series of stock of the corporation without certificates.

3.03    TRANSFER OF SHARES. The shares of the capital stock of the corporation are transferable only on the books of the corporation and, if such shares are certificated, upon surrender of the certificate therefor, properly endorsed for transfer, and the presentation of such evidences of ownership and validity of the assignment as the corporation may require.


1



3.04    REGISTERED SHAREHOLDERS. The corporation shall be entitled to treat the person in whose name any share of stock is registered as the owner thereof for purposes of dividends and other distributions in the course of business, or in the course of recapitalization, consolidation, merger, reorganization, sale of assets, liquidation or otherwise and for the purpose of votes, approvals and consents by shareholders, and for the purpose of notices to shareholders, and for all other purposes whatever, and shall not be bound to recognize any equitable or other claim to or interest in such shares on the part of any other person, whether or not the corporation shall have notice thereof, save as expressly required by the laws of the State of Michigan.

3.05    LOST OR DESTROYED CERTIFICATES. Upon the presentation to the corporation of a proper affidavit attesting the loss, destruction or mutilation of any certificate or certificates for shares of stock of the corporation, the Board of Directors shall direct the issuance of a new certificate or certificates to replace the certificates so alleged to be lost, destroyed or mutilated. The Board of Directors may require as a condition precedent to the issuance of new certificates any or all of the following: (a) presentation of additional evidence or proof of the loss, destruction or mutilation claimed; (b) advertisement of loss in such manner as the Board of Directors may direct or approve; (c) a bond or agreement of indemnity, in such form and amount and with such sureties, or without sureties, as the Board of Directors may direct or approve; (d) the order or approval of a court or judge.

ARTICLE IV
SHAREHOLDERS AND MEETINGS OF SHAREHOLDERS

4.01    PLACE OF MEETINGS. All meetings of shareholders shall be held at the principal office of the corporation or at such other place as shall be determined by the Board of Directors and stated in the notice of meeting.

4.02    ANNUAL MEETING. The annual meeting of the shareholders of the corporation shall be held on the third Monday of the fourth calendar month after the end of the corporation’s fiscal year at 2 o’clock in the afternoon, or on such other date and time as shall be determined by the Board of Directors prior to the end of the second calendar quarter. Directors shall be elected at each annual meeting and such other business transacted as may come before the meeting.

4.03    SPECIAL MEETINGS. Special meetings of shareholders may be called by the Board of Directors, the Chair of the Board (if such office is filled) or the President and shall be called by the President or Secretary at the written request of shareholders holding a majority of the shares of stock of the corporation outstanding and entitled to vote. The request shall state the purpose or purposes for which the meeting is to be called.

4.04    NOTICE OF MEETING OF SHAREHOLDERS. Notwithstanding anything to the contrary in these Bylaws (including Article VI, Section 6.01), written notice of each meeting of shareholders, stating the time, place, if any, and purposes thereof, shall be given to each shareholder entitled to vote at the meeting not less than ten nor more than sixty days before the date fixed for the meeting, either personally, by mail, or, if authorized by the Board of Directors, by a form of electronic transmission to which the shareholder has consented. For the purposes of these Bylaws, “electronic transmission” means any form of communication that does not directly involve the physical transmission of paper, that creates a record that may be retained and retrieved by the recipient, and that may be reproduced in paper form by the recipient through an automated process. Notice of a meeting need not be given to any shareholder who signs a waiver of notice before or after the meeting. Attendance of a shareholder at a meeting shall constitute both: (a) a waiver of notice or defective notice except when the shareholder attends a meeting for the express purpose of objecting, at the beginning of the meeting, to holding the meeting or transacting any business because the meeting has not been lawfully called or convened, and (b) a waiver of objection to consideration of a particular matter at the meeting that is not within the purpose or purposes described in the meeting notice, except when the shareholder objects to considering the matter when it is presented.

4.05    RECORD DATES. The Board of Directors, the Chair of the Board (if such office is filled) or the President may fix in advance a date as the record date for the purpose of determining shareholders entitled to notice of and to vote at a meeting of shareholders or an adjournment thereof, or to express consent or to dissent from a proposal without a meeting, or for the purpose of determining shareholders entitled to receive payment of a dividend or allotment of a right, or for the purpose of any other action. The date fixed shall not be more than 60 nor less than 10 days before

2



the date of the meeting, nor more than 60 days before any other action. In such case only such shareholder as shall be shareholders of record on the date so fixed shall be entitled to notice of and to vote at such meeting or adjournment therefor, or to express consent or to dissent from such proposal, or to receive payment of such dividend or to receive such allotment of rights, or to participate in any other action, as the case may be, notwithstanding any transfer of any stock on the books of the corporation, or otherwise, after any such record date. Nothing in this Bylaw shall affect the rights of a shareholder and his or her transferee or transferor as between themselves.

4.06    LIST OF SHAREHOLDERS. The Secretary of the corporation or the agent of the corporation having charge of the stock transfer records for shares of the corporation shall make and certify a complete list of the shareholders entitled to vote at a shareholders’ meeting or any adjournment thereof. The list shall be arranged alphabetically within each class and series, with the address of, and the number of shares held by, each shareholder; be produced at the time and place of the meeting; be subject to inspection by any shareholder during the whole time of the meeting; and be prima facie evidence as to who are the shareholders entitled to examine the list or vote at the meeting.

4.07    QUORUM. Unless a greater or lesser quorum is required in the Articles of Incorporation or by the laws of the State of Michigan, the shareholders present at a meeting in person or by proxy who, as of the record date for such meeting, were holders of a majority of the outstanding shares of the corporation entitled to vote at the meeting shall constitute a quorum at the meeting. Whether or not a quorum is present, a meeting of shareholders may be adjourned by a vote of the shares present in person or by proxy. When the holders of a class or series of shares are entitled to vote separately on an item of business, this Bylaw applies in determining the presence of a quorum of such class or series for transaction of such item of business.

4.08    PROXIES. A shareholder entitled to vote at a meeting of shareholders or to express consent or dissent without a meeting may authorize one or more other persons to act for him or her by proxy. The following methods constitute a valid means by which a shareholder may grant authority to another person to act as proxy: (a) the execution of a writing authorizing another person or persons to act for the shareholder as proxy. Execution may be accomplished by the shareholder or by an authorized officer, director, employee, or agent signing the writing or causing his or her signature to be affixed to the writing by any reasonable means including, but not limited to, facsimile signature; and (b) transmitting or authorizing the transmission by electronic transmission to the person who will hold the proxy or to a proxy solicitation firm, proxy support service organization, or similar agent fully authorized by the person who will hold the proxy to receive that transmission. Any electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic transmission was authorized by the shareholder. If an electronic transmission is determined to be valid, the inspectors, or, if there are no inspectors, the persons making the determination shall specify the information upon which they relied.

4.09    INSPECTORS OF ELECTION. The Board of Directors, in advance of a shareholders’ meeting, may appoint one or more inspectors to act at the meeting or any adjournment thereof. If inspectors are not so appointed, the person presiding at the shareholders’ meeting may, and on request of a shareholder entitled to vote thereat shall, appoint one or more inspectors. In case a person appointed fails to appear or act, the vacancy may be filled by appointment made by the Board of Directors in advance of the meeting or at the meeting by the person presiding thereat. If appointed, the inspectors shall determine the number of shares outstanding and the voting power of each, the shares represented at the meeting, the existence of a quorum and the validity and effect of proxies, and shall receive votes, ballots or consents, hear and determine challenges and questions arising in connection with the right to vote, count and tabulate votes, ballots or consents, determine the result, and do such acts as are proper to conduct the election or vote with fairness to all shareholders. On request of the person presiding at the meeting or a shareholder entitled to vote thereat, the inspectors shall make and execute a written report to the person presiding at the meeting of any of the facts found by them and matters determined by them. The report shall be prima facie evidence of the facts stated and of the vote as certified by the inspectors.

4.10    VOTING. Each outstanding share is entitled to one vote on each matter submitted to a vote, unless otherwise provided in the Articles of Incorporation. Votes shall be cast in writing, signed by the shareholder or his or her proxy. When an action, other than the election of directors, is to be taken by a vote of the shareholders, it shall be authorized by a majority of the votes cast by the holders of shares entitled to vote thereon, unless a greater plurality

3



is required by the Articles of Incorporation or by the laws of the State of Michigan. Except as otherwise provided by the Articles of Incorporation, directors shall be elected by a plurality of the votes cast at any election.

4.11    SHAREHOLDER PROPOSALS. Except as otherwise provided by statute, the corporation’s Articles of Incorporation or these Bylaws:

(a)No matter may be presented for shareholder action at an annual or special meeting of shareholders unless such matter is: (i) specified in the notice of the meeting (or any supplement to the notice) given by or at the direction of the Board of Directors; (ii) otherwise presented at the meeting by or at the direction of the Board of Directors; (iii) properly presented for action at the meeting by a shareholder in accordance with the notice provisions set forth in this Section 4.11 and any other applicable requirements; or (iv) a procedural matter presented, or accepted for presentation, by the Chair in his or her sole discretion

(b)For a matter to be properly presented by a shareholder, the shareholder must have given timely notice of the matter in writing to the Secretary of the corporation. To be timely, the notice must be delivered to or mailed to and received at the principal executive offices of the corporation not less than 120 calendar days prior to the date corresponding to the date of the corporation’s proxy statement or notice of meeting released to shareholders in connection with the last preceding annual meeting of shareholders in the case of an annual meeting (unless the corporation did not hold an annual meeting within the last year, or if the date of the upcoming annual meeting changed by more than thirty days from the date of the last preceding meeting, then the notice must be delivered or mailed and received not more than ten days after the earlier of the date of the notice of the meeting or public disclosure of the date of the meeting), and not more than ten days after the earlier of the date of the notice of the meeting or public disclosure of the date of the meeting in the case of a special meeting. The notice by the shareholder must set forth: (i) a brief description of the matter the shareholder desires to present for shareholder action; (ii) the name and record address of the shareholder proposing the matter for shareholder action; (iii) the class and number of shares of capital stock of the corporation that are beneficially owned by the shareholder; and (iv) any material interest of the shareholder in the matter proposed for shareholder action. For purposes of this Section 4.11(b), “public disclosure” means disclosure in a press release reported by the Dow Jones News Service, Associated Press or other comparable national financial news service or in a document publicly filed by the corporation with the Securities and Exchange Commission pursuant to Section 13, 14 or 15 of the Securities Exchange Act of 1934, as amended.

(c)Except to the extent that a shareholder proposal submitted pursuant to this Section 4.11 is not made available at the time of mailing, the notice of the purposes of the meeting shall include the name and address of and the number of shares of the voting security held by the proponent of each shareholder proposal

(d)Notwithstanding the above, if the shareholder desires to require the corporation to include the shareholder’s proposal in the corporation’s proxy materials, matters and proposals submitted for inclusion in the corporation’s proxy materials shall be governed by the solicitation rules and regulations of the Securities Exchange Act of 1934, as amended, including without limitation Rule 14a-8.

4.12    CONDUCT, ADJOURNMENT, AND POSTPONEMENT OF MEETINGS.

(a)Shareholders’ meetings shall be presided over by the Chair of the Board or, in his absence, by the Chief Executive Officer of the corporation or, in the absence of both of them, another director or officer designated by the Board of Directors. Such person is referred to in this Section 4.12 as the presiding officer or as the chairman of the meeting.
 
(b)The presiding officer shall determine all questions of order or procedure (and the presiding officer's rulings shall be final) and may, in his or her discretion, adjourn or postpone a meeting of shareholders regardless of whether a quorum is present.

(c)Any previously scheduled shareholders’ meeting may be postponed by resolution of the Board of Directors, or by any officer or director designated by the Board of Directors, upon public notice given prior to the time previously scheduled for such shareholders’ meetings.

4




(d)For the avoidance of doubt, any reference to a shareholders’ meeting in these Bylaws shall include any adjournment or postponement thereof.

ARTICLE V
DIRECTORS

5.01    NUMBER. The business and affairs of the corporation shall be managed by a Board of not less than five (5) nor more than twenty-five (25) directors as shall be fixed from time to time by the Board of Directors. The directors need not be residents of Michigan or shareholders of the corporation.

5.02    ELECTION, RESIGNATION AND REMOVAL. Directors shall be elected at each annual meeting of the shareholders, each to hold office until the next annual meeting of shareholders and until his or her successor is elected and qualified, or until his or her resignation or removal. A director may resign by written notice to the corporation. The resignation is effective upon its receipt by the corporation or a subsequent time as set forth in the notice of resignation. A director or the entire Board of Directors may be removed, with or without cause, by vote of the holders of a majority of the shares entitled to vote at an election of directors.

5.03    NOMINATIONS OF DIRECTOR CANDIDATES.

(a)Nominations of candidates for election to the Board of Directors of the corporation at any annual meeting of shareholders or at any special meeting of shareholders called for election of directors (an “Election Meeting”) may be made by the Board of Directors or by a shareholder of record of shares of a class entitled to vote at such Election Meeting.

(b)Nominations made by the Board of Directors shall be made at a meeting of the Board of Directors, or by written consent of directors in lieu of a meeting, not less than ten days prior to the date of an Election Meeting; provided, that approval by the Board of Directors of the corporation’s proxy statement with respect to an Election Meeting in which nominees for director are named shall constitute the nominations of the Board of Directors.

(c)A shareholder of record of shares of a class entitled to vote at an Election Meeting may make a nomination at an Election Meeting if, and only if, such shareholder shall have first delivered, not less than 120 days prior to the date of the Election Meeting in the case of an annual meeting, and not more than seven days following the date of notice of the Election Meeting in the case of a special meeting, a notice to the Secretary of the corporation setting forth with respect to each proposed nominee: (i) the name, age, business address and residence address of such nominee; (ii) the principal occupation or employment of such nominee; (iii) the number of shares of capital stock of the corporation which are beneficially owned by such nominee; (iv) a statements that such nominee is willing to be nominated and to serve if elected; and (v) such other information concerning such nominee as would be required under the rules of the Securities and Exchange Commission to be provided in a proxy statement soliciting proxies for the election of such nominee.

(d)If the chair of the Election Meeting determines that a nomination was not made in accordance with the foregoing procedures, such nomination shall be void and all votes cast in favor of election of a person so nominated shall be disregarded.

5.04    VACANCIES. Vacancies in the Board of Directors occurring by reason of death, resignation, removal, increase in the number of directors or otherwise shall be filled by the affirmative vote of a majority of the remaining directors though less than a quorum of the Board of Directors, unless filled by proper action of the shareholders of the corporation. Each person so elected shall be a director for a term of office continuing only until the next election of directors by the shareholders.

5.05    ANNUAL MEETING. The Board of Directors shall meet each year following the annual meeting of the shareholders, for the purpose of election of officers and consideration of such business that may properly be brought before the meeting.

5




5.06    REGULAR AND SPECIAL MEETINGS. Regular meetings of the Board of Directors may be held at such times and places as the majority of the directors may from time to time determine at a prior meeting or as shall be directed or approved by the vote or written consent of all the directors. Special meetings of the Board may be called by the Chair of the Board (if such office is filled) or the President and shall be called by the President or Secretary upon the written request of any two directors.

5.07    NOTICES. No notice shall be required for annual or regular meetings of the Board or for adjourned meetings, whether regular or special. Three days’ written notice shall be given for special meetings of the Board, and such notice shall state the time, place and purpose or purposes of the meeting.

5.08    QUORUM. A majority of the Board of Directors then in office, or of the members of a committee thereof, constitutes a quorum for the transaction of business. The vote of a majority of the directors present at any meeting at which there is a quorum shall be the acts of the Board or of the committee, except as a larger vote may be required by the laws of the State of Michigan. A member of the Board or of a committee designated by the Board may participate in a meeting by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other. Participation in a meeting in this manner constitutes presence in person at the meeting.

5.09    EXECUTIVE AND OTHER COMMITTEES. The Board of Directors may, by resolution passed by a majority of the whole Board, appoint three or more members of the Board as an executive committee to exercise all powers and authorities of the Board in management of the business and affairs of the corporation, provided, however, that such committee shall not have power or authority to:

(a)amend the Articles of Incorporation;

(b)adopt an agreement of merger or consolidation;

(c)recommend to shareholders the sale, lease or exchange of all or substantially all of the corporation’s property and assets;

(d)recommend to shareholders a dissolution of the corporation or revocation of a dissolution;

(e)amend these Bylaws;

(f)fill vacancies in the Board;

(g)fix the compensation of the directors for serving on the Board or on a committee; or

(h)unless expressly authorized by the Board, declare a dividend or authorize the issuance of stock.

The Board of Directors from time to time may, by like resolution, appoint such other committees of one or more directors to have such authority as shall be specified by the Board in the resolution making such appointments. The Board of Directors may designate one or more directors as alternate members of any committee who may replace an absent or disqualified member at any meeting thereof.

5.10    DISSENTS. A director who is present at a meeting of the Board of Directors, or a committee thereof of which he or she is a member, at which action on a corporate matter is taken is presumed to have concurred in that action unless his or her dissent is entered in the minutes of the meeting or unless he or she files his or her written dissent to the action with the person acting as secretary of the meeting before the adjournment thereof or shall forward such dissent by registered mail to the Secretary of the corporation promptly after the adjournment of the meeting. Such right to dissent does not apply to a director who voted in favor of such action. A director who is absent from a meeting of the Board, or a committee thereof of which he or she is a member, at which any such action is taken is presumed

6



to have concurred in the action unless he or she files his or her written dissent with the Secretary of the corporation within a reasonable time after he or she has knowledge of the action.

5.11    COMPENSATION. The Board of Directors, by affirmative vote of a majority of directors in office and irrespective of any personal interest of any of them, may establish reasonable compensation of directors for services to the corporation as directors or officers.

ARTICLE VI
NOTICES, WAIVERS OF NOTICE AND MANNER OF ACTING

6.01    NOTICES. All notices of meetings required to be given to shareholders, directors or any committee of directors may be given by mail or by electronic transmission to any shareholder, director or committee member at his or her last address as it appears on the books of the corporation. Such notice shall be deemed to be given at the time when the same shall be mailed or otherwise dispatched.

6.02    WAIVER OF NOTICE. Notice of the time, place and purpose of any meeting of shareholders, directors or committee of directors may be waived in writing or by electronic transmission, either before or after the meeting, or in such other manner as may be permitted by the laws of the State of Michigan. Attendance of a person at any meeting of shareholders, in person or by proxy, or at any meeting of directors or of a committee of directors, constitutes a waiver of notice of the meeting except when the person attends the meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened.

6.03    ACTION WITHOUT A MEETING. Any action required or permitted at any meeting of shareholders or directors or committee of directors may be taken without a meeting, without prior notice and without a vote, if all of the shareholders or directors or committee members entitled to vote thereon consent thereto in writing.

ARTICLE VII
OFFICERS

7.01    NUMBER. The Board of Directors shall elect or appoint a Chair of the Board, a Chief Executive Officer, a President, a Secretary, a Treasurer, and may elect a Vice Chair of the Board and one or more other officers as the Board of Directors may from time to time determine. The Chief Executive Officer shall also have authority to appoint or remove any officer with a title below Executive Vice President as from time to time the Chief Executive Officer determines. The Chair of the Board, the President and the Chief Executive Officer, if such person is not also the President, shall be members of the Board of Directors. Any two or more offices, except those of President and Vice President and those of Chief Executive Officer and Vice President, may be held by the same person, but no officer shall execute, acknowledge or verify an instrument in more than one capacity.

7.02    TERM OF OFFICE, RESIGNATION AND REMOVAL. The Chair of the Board and each officer shall hold office for the term for which he or she is elected or appointed and until his or her successor is elected or appointed and qualified, or until his or her resignation or removal. The Chair of the Board and any officer may resign by written notice to the corporation. The resignation is effective upon its receipt by the corporation or at a subsequent time specified in the notice of resignation. An officer may be removed with or without cause. The removal of an officer shall be without prejudice to his or her contract rights, if any. The election or appointment of an officer does not of itself create contract rights.

7.03    VACANCIES. The Board of Directors may fill any vacancies in the Chair of the Board position or any office occurring for whatever reason.

7.04    AUTHORITY. The Chair of the Board and all officers, employees and agents of the corporation shall have such authority and perform such duties in the conduct and management of the business and affairs of the corporation as may be designated by the Board of Directors and these Bylaws.


7



ARTICLE VIII
DUTIES OF OFFICERS

8.01    CHAIR OF THE BOARD. The Chair of the Board shall preside at all meetings of the shareholders and of the Board of Directors at which he or she is present. He or she shall have such other duties and powers as may be imposed upon or given to him or her by the Board of Directors.

8.02    CHIEF EXECUTIVE OFFICER. The Chief Executive Officer shall see that all orders and resolutions of the Board are carried into effect, and he or she shall have the general and active powers of supervision and management usually vested in the chief executive officer of a corporation, including the authority to vote all securities of other corporations and business organizations which are held by the corporation. In the absence or disability of the Chair of the Board, he or she also shall perform the duties and execute the powers of the Chair of the Board as set forth in these Bylaws.

8.03    PRESIDENT. The President shall have such duties as may be assigned to him or her from time to time by the Chief Executive Officer or the Board of Directors. The President may also be the Chief Executive Officer. In the absence or disability of the Chief Executive Officer, the President shall perform the duties and execute the powers of the Chief Executive Officer as set forth in these Bylaws.

8.04    VICE PRESIDENTS. The Vice Presidents, in order of their seniority based upon executive title, shall, in the absence or disability of the President, perform his or her duties and exercise his or her powers and shall perform such other duties as the Board of Directors, the Chief Executive Officer or the President may from time to time prescribe.

8.05    SECRETARY. The Secretary shall attend all meetings of the Board of Directors and of shareholders and shall record all votes and minutes of all proceedings in a book to be kept for that purpose. He or she shall give or cause to be given notice of all meetings of the shareholders and of the Board of Directors. He or she shall keep in safe custody the seal of the corporation, if any, and, when authorized by the Board, affix the same to any instrument requiring it, and when so affixed it shall be attested by his or her signature, or by the signature of the Treasurer or an Assistant Secretary. The Secretary may delegate any of his or her duties, powers and authorities to one or more Assistant Secretaries, unless such delegation is disapproved by the Board.

8.06    TREASURER. The Treasurer shall have the custody of the corporate funds and securities; shall keep full and accurate accounts of receipts and disbursements in books of the corporation; and shall deposit all moneys and other valuable effects in the name and to the credit of the corporation in such depositories as may be designated by the Board of Directors. He or she shall render to the Chief Executive Officer, the President and directors, whenever they may require it, an account of his or her transactions as Treasurer and of the financial condition of the corporation. The Treasurer may delegate any of his or her duties, powers and authorities to one or more Assistant Treasurers unless such delegation be disapproved by the Board of Directors. The Board of Directors may designate the individual who serves as Treasurer to also serve as Chief Financial Officer of the corporation.

8.07    ASSISTANT SECRETARIES AND TREASURERS. The Assistant Secretaries, in the order of their seniority based upon executive title, shall perform the duties and exercise the powers and authorities of the Secretary in case of his or her absence or disability. The Assistant Treasurers, in the order of their seniority based upon executive title, shall perform the duties and exercise the powers and authorities of the Treasurer in case of his or her absence or disability. The Assistant Secretaries and Assistant Treasurers shall also perform such duties as may be delegated to them by the Secretary and Treasurer, respectively, and also such duties as the Chief Executive Officer, the President, or the Board of Directors may prescribe.

8.08    OTHER OFFICERS. The Board of Directors may, from time to time, appoint such other officers of the corporation as the Board of Directors may consider appropriate. Such officers shall perform such duties and exercise such authority as the Board of Directors may prescribe.


8



8.09    EXECUTIVE OFFICERS. The Chief Executive Officer, President, Secretary and Treasurer, together with such other officers specifically designated by the Board of Directors, shall be known as the executive officers and shall have all of the usual powers and shall perform all of the usual duties incident to their respective offices.

ARTICLE IX
CERTAIN GOVERNANCE MATTERS

9.01    INTERPRETATION; DEFINITIONS.

(a)    The provisions of this Article IX shall apply notwithstanding anything to the contrary set forth in these Bylaws. In the event of any inconsistency between any provision of this Article IX and any other provision of these Bylaws, such provision of this Article IX shall control.

(b)    The following definitions shall apply to this Article IX and otherwise as applicable in these Bylaws:

(i)“Designated Exchange” means the primary stock exchange on which the corporation’s common stock is listed.

(ii)“Effective Time” shall have the meaning set forth in the Agreement and Plan of Merger, dated as of January 27, 2019, by and between TCF and Chemical, as it may have been amended, restated, supplemented or otherwise modified from time to time.

(iii)“Entire Board of Directors” means the total number of directors which the corporation would have if there were no vacancies.

(iv)“Legacy TCF” means TCF Financial Corporation, a Delaware corporation, which has merged with and into the corporation effective as of the Effective Time.

(v)“Legacy TCF Directors” shall mean the directors as of the Effective Time who were directors of Legacy TCF as of immediately prior to the Effective Time and who were designated to be directors by the Board of Directors of Legacy TCF prior to the Effective Time and any additional directors nominated by the Legacy TCF Directors Nominating Committee pursuant to Section 9.03(e) of this Article IX.

(vi)“Legacy TCF Directors Nominating Committee” shall mean a committee of the Board of Directors comprised of all of the Legacy TCF Directors who satisfy the independence requirements (and any other requirements) for nominating committee membership under the rules of the Designated Exchange.

(vii)“Legacy Chemical” means Chemical, a Michigan corporation, as in existence immediately prior to the Effective Time.

(viii)“Legacy Chemical Directors” shall mean the directors as of the Effective Time who were directors of Legacy Chemical as of immediately prior to the Effective Time and who were designated to be directors by the Board of Directors of Legacy Chemical prior to the Effective Time and any additional directors nominated by the Legacy Chemical Directors Nominating Committee pursuant to Section 9.03(d) of this Article IX.

(ix)“Legacy Chemical Directors Nominating Committee” shall mean a committee of the Board of Directors comprised of all of the Legacy Chemical Directors who satisfy the independence requirements (and any other requirements) for nominating committee membership under the rules of the Designated Exchange.

(x)“Specified Period” shall mean the period beginning at the Effective Time and ending on the thirty-six (36) month anniversary of the Effective Time.


9



9.02    CHAIR; VICE CHAIR; CEO AND PRESIDENT; LEAD DIRECTOR.

(a)Effective as of October 28, 2020, Mr. Gary Torgow shall continue to serve as Chair of the corporation and the Board of Directors, Mr. David T. Provost shall become and serve as Chief Executive Officer of the corporation, Mr. Thomas C. Shafer shall become and serve as Vice Chair of the corporation, and Mr. Vance K. Opperman shall continue to serve as Lead Director of the Board of Directors. The Lead Director shall qualify as an independent director under the rules of the Designated Exchange, shall chair any meeting of the independent directors in executive session, and shall, among other things, have the power and authority to (i) preside at meetings of the Board of Directors at which the Chair is not present, including presiding at executive sessions, (ii) work with the Chair and management to determine the information and materials provided to members of the Board of Directors, (iii) consult with the Chair on such other matters as are pertinent to the Board of Directors and the corporation, (iv) call meetings of the independent directors, (v) communicate and consult directly with regulators upon request, (vi) serve as a liaison between the Chair and the other independent directors and (vii) perform such other duties, powers and authorities as the Board of Directors, upon the affirmative vote of at least seventy-five percent (75%) of the Entire Board of Directors, may give to the Lead Director from time to time.

(b)During the Specified Period, (i) any removal of any of the individuals serving in the capacities set forth in subsection (a) above, (ii) any amendment or modification to any employment or similar agreement with any of them to the extent such amendment or modification would adversely affect such individual, (iii) any termination of their employment by the corporation, (iv) any grant or delegation of duties, powers and authorities to the Lead Director pursuant to clause (vii) of subsection (a) above, or (v) any modification to any of their respective duties, authority or reporting relationships as set forth in Article VIII of these Bylaws shall, in each case, require the affirmative vote of at least seventy-five percent (75%) of the Entire Board of Directors.

(c)During the Specified Period, upon the death, resignation, removal, disqualification or other cessation of service by any of the individuals serving in the capacities set forth in subsection (a) above (other than the Lead Director) (or any of such individuals’ successors selected and appointed pursuant to this subsection (c)), an individual approved by the affirmative vote of at least seventy-five percent (75%) of the Entire Board of Directors shall be appointed to serve in such capacity.

(d)During the Specified Period, upon the death, resignation, removal, disqualification or other cessation of service by the Lead Director (or any of his or her successors selected and appointed pursuant to this subsection (d)), an individual selected by the Legacy TCF Directors Nominating Committee shall be appointed to serve as Lead Director.


9.03    COMPOSITION OF THE BOARD OF DIRECTORS. From October 28, 2020, and for the remainder of the Specified Period:

(a)the Entire Board of Directors shall be comprised of sixteen (16) Directors, of which nine (9) shall be Legacy Chemical Directors (three of whom shall be Mr. Gary Torgow, Mr. David T. Provost and Mr. Thomas C. Shafer, and six other Legacy Chemical Directors who qualify as independent directors under the rules of the Designated Exchange) and seven (7) shall be Legacy TCF Directors (one of whom shall be Mr. Vance K. Opperman, and six other Legacy TCF Directors who qualify as independent directors under the rules of the Designated Exchange); provided, however, that if a vacancy occurs among the Legacy Chemical Directors prior to the end of the Specified Period, such vacancy shall be filled by the Legacy TCF Directors Nominating Committee and thereafter the Entire Board of Directors shall be comprised of eight (8) Legacy Chemical Directors and eight (8) Legacy TCF Directors;

(b)all vacancies resulting from the cessation of service by any Legacy Chemical Director for any reason shall be filled by the Board of Directors with a nominee selected by the Legacy Chemical Directors Nominating Committee, except as otherwise provided in clause (a) above;

(c)all vacancies resulting from the cessation of service by any Legacy TCF Director for any reason shall be filled by the Board of Directors with a nominee selected by the Legacy TCF Directors Nominating Committee;


10



(d)the Legacy Chemical Directors Nominating Committee shall have the exclusive authority to nominate, on behalf of the Board of Directors, directors for election at each annual meeting, or at any special meeting at which Directors are to be elected, to fill each seat previously held by a Legacy Chemical Director, except as otherwise provided in clause (a) above; and

(e)the Legacy TCF Directors Nominating Committee shall have the exclusive authority to nominate, on behalf of the Board of Directors, directors for election at each annual meeting, or at any special meeting at which directors are to be elected, to fill each seat previously held by a Legacy TCF Director.
  
9.04    COMPOSITION OF COMMITTEES.

(a)During the Specified Period, each committee of the Board of Directors shall (a) have at least four (4) members and, (b) be composed of fifty percent (50%) Legacy Chemical Directors and fifty percent (50%) Legacy TCF Directors (subject to compliance with any independence requirements, and any other requirements, for membership on the applicable committee under the rules of the Designated Exchange).

(b)The Board of Directors shall constitute a Legacy TCF Directors Nominating Committee, which shall be comprised of all of the Legacy TCF Directors who satisfy the independence requirements (and any other requirements) for nominating committee membership under the rules of the Designated Exchange. At the end of the Specified Period, the Legacy TCF Directors Nominating Committee shall be automatically disbanded.

(c)The Board of Directors shall constitute a Legacy Chemical Directors Nominating Committee, which shall be comprised of all of the Legacy Chemical Directors who satisfy the independence requirements (and any other requirements) for nominating committee membership under the rules of the Designated Exchange. At the end of the Specified Period, the Legacy Chemical Directors Nominating Committee shall be automatically disbanded.

9.05    CORPORATE NAME; HEADQUARTERS. During the Specified Period, (a) the name of the corporation shall be TCF Financial Corporation, (b) the shares of common stock of the corporation shall be traded on the Designated Exchange under the ticker symbol “TCBF,” and (c) the headquarters and principal office of the corporation shall be located in Detroit, Michigan. During the Specified Period, the corporation shall cause TCF National Bank to have its main office in Sioux Falls.

9.06    AMENDMENTS. During the Specified Period, the provisions of this Article IX, and any other provision of these Bylaws that sets forth the authority and responsibility of the Chair, Vice Chair, the Lead Director, the Chief Executive Officer or President, may be modified, amended or repealed, and any Bylaw provision or other resolution inconsistent with this Article IX may be adopted, by the Board only by (and any such modification, amendment, repeal or inconsistent Bylaw provisions and other resolutions may be proposed or recommended by the Board for adoption by the shareholders of the corporation only by) an affirmative vote of at least seventy-five percent (75%) of the Entire Board of Directors.

ARTICLE X
SPECIAL CORPORATE ACTS

10.01    ORDERS FOR PAYMENT OF MONEY. All checks, drafts, notes, bonds, bills of exchange and orders for payment of money of the corporation shall be signed by such officer or officers or such other person or persons as the Board of Directors may from time to time designate.

10.02    CONTRACTS AND CONVEYANCES. The Board of Directors of the corporation may in any instance designate the officer and/or agent who shall have authority to execute any contract, conveyance, mortgage or other instrument on behalf of the corporation, or may ratify or confirm any execution. When the execution of any instrument has been authorized without specification of the executing officers or agents, any executive officer of the corporation may execute the same in the name and on behalf of this corporation and may affix the corporate seal thereto.


11



ARTICLE XI
BOOKS AND RECORDS

11.01    MAINTENANCE OF BOOKS AND RECORDS. The proper officers and agents of the corporation shall keep and maintain such books, records and accounts of the corporation’s business and affairs, minutes of the proceedings of its shareholders, Board and committees, if any, and such stock ledgers and lists of shareholders, as the Board of Directors shall deem advisable, and as shall be required by the laws of the State of Michigan and other states or jurisdictions empowered to impose such requirements. Books, records and minutes may be kept within or without the State of Michigan in a place which the Board shall determine.

11.02    RELIANCE ON BOOKS AND RECORDS. In discharging his or her duties, a director or an officer of the corporation, when acting in good faith, may rely upon the opinion of counsel for the corporation, upon the report of an independent appraiser selected with reasonable care by the Board, or upon financial statements of the corporation represented to him or her to be correct by the President or the officer of the corporation having charge of its books of account, or stated in a written report by an independent public or certified public accountant or firm of such accountants fairly to reflect the financial condition of the corporation.

ARTICLE XII
INDEMNIFICATION

12.01    INDEMNIFICATION. The corporation shall provide indemnification to persons who serve or have served as directors, officers, employees or agents of the corporation, and to persons who serve or have served at the request of the corporation as directors, officers, employees, partners or agents of another foreign or domestic corporation, partnership, joint venture, trust or other enterprise, whether for profit or not, to the fullest extent permitted by the Michigan Business Corporation Act, as the same now exists or may hereafter be amended.


ARTICLE XIII
EXCLUSIVE FORUM

13.01    EXCLUSIVE FORUM. Unless the corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the corporation, (b) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the corporation to the corporation or the corporation’s current or former shareholders (including beneficial owners of the corporation’s capital stock), (c) any action asserting a claim arising pursuant to any provision of the Michigan Business Corporation Act or the corporation’s articles of incorporation or bylaws (as either may be amended from time to time), or (d) any action asserting a claim governed by the internal affairs doctrine, in each case, shall be the federal district court for the Eastern District of Michigan, Southern Division (or, if the federal district court does not have jurisdiction, the Circuit Courts of the State of Michigan located in Oakland County). If any action the subject matter of which is within the scope of the immediately preceding sentence is filed in a court other than a court located within the State of Michigan (a “Foreign Action”) directly or derivatively by any debtholder or shareholder or other equityholder, such debtholder or shareholder or other equityholder shall, to the fullest extent permitted by applicable law, be deemed to have consented to (i) the personal jurisdiction of the federal and state courts located within the State of Michigan in connection with any action brought in any such court to enforce the immediately preceding sentence and (ii) having service of process made upon such debtholder or shareholder or other equityholder in any such action by service upon such debtholder’s or shareholder’s or other equityholder’s counsel in the Foreign Action as agent for such debtholder or shareholder or equityholder. Any person or entity purchasing or otherwise acquiring or holding any debt or capital stock or other equity interests of the corporation shall be deemed to have notice of and consented to the provisions of this Section 13.01.


12



ARTICLE XIV
AMENDMENTS; INTERPRETATION AND SEVERABILITY

14.01    AMENDMENTS. The Bylaws of the corporation may be amended, altered or repealed, in whole or in part, by the shareholders or by the Board of Directors at any meeting duly held in accordance with these Bylaws, provided that notice of the meeting includes notice of the proposed amendment, alternative or repeal.

14.02    INTERPRETATION AND SEVERABILITY. Whenever possible, each provision contained in these Bylaws shall be interpreted in such manner as to be valid and effective under applicable law. Each of the Sections of these Bylaws, and each of the clauses set forth therein, shall be deemed separate and independent, and should any part (including any words or phrases) of any such Section or clause be declared invalid or unenforceable by any court of competent jurisdiction, such invalidity or unenforceability shall in no way render invalid or unenforceable any other part thereof or any separate Section or clause of these Bylaws that is not declared invalid or unenforceable and, to the extent possible, effect shall be given to the intent manifested by the Section or clause or part thereof that is declared invalid or unenforceable.


13


Exhibit 10.1
Execution Version
SEPARATION AND RELEASE AGREEMENT

THIS SEPARATION AND RELEASE AGREEMENT (the “Release”) is made by and between TCF Financial Corporation (collectively with TCF National Bank and its predecessors, successors, assigns, parents, affiliates, subsidiaries, and related companies and all of their affiliates, “TCF”), and Craig R. Dahl (the “Executive”) (in the aggregate, the “Parties”).

WHEREAS, Executive’s employment with TCF will end effective October 27, 2020 and that such separation is without Cause; and
WHEREAS, pursuant to Executive’s separation and agreement to provide advisory services to TCF through January 29, 2021, TCF will provide certain payments and benefits to Executive in accordance with the terms below and that are contingent upon TCF’s receipt of a general release from Executive;
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is agreed between the Parties as follows:
1.Advisory Services. Executive agrees to provide post-employment advisory services to TCF through January 29, 2021 to ensure a smooth transition. Such services shall be on an as-needed basis as reasonably requested by TCF’s Executive Chairman, to be performed at such locations and times as necessary. The level of services is intended to constitute less than 20% of Executive’s average weekly services to TCF over the prior 36-month period. Compensation for Executive’s advisory services is incorporated within the payments and benefits provided hereunder.
 
2.Compensation. Subject to the terms and conditions hereof and Executive’s continued compliance with the terms and covenants set forth in Section 5 of his Amended and Restated Employment Agreement with TCF, dated as of November 6, 2019 (the “Employment Agreement”), as well as his cooperation providing the advisory services described above and conditioned on Executive’s execution and submission of this Release within 60 days following his employment termination date, with no revocation, TCF shall pay Executive: (a) one lump sum payment of $11,213,931, less applicable withholding taxes, on the first payroll date after the Release becomes enforceable, with all revocation dates having expired, provided that if such 60-day period spans two calendar years, the payment shall be made in the second calendar year; (b) $1,500,000, payable in equal monthly installments on the first day of each month for a period of eighteen months, commencing on May 1, 2021; plus (iii) if Executive elects COBRA coverage, payment of his COBRA premiums until the earlier of the date on which he is no longer eligible for COBRA or 24 months from his employment termination date. Executive’s outstanding equity awards shall vest as of his employment termination date and be paid out or settled, as applicable, in accordance with their terms for involuntary employment termination without cause, as defined therein. No payment made under this Section 2 is a payment made in connection with a Change in Control under Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”). Executive acknowledges that the payments and benefits provided hereunder are in full satisfaction of and exceed any payments and benefits owed to Executive under his Employment Agreement or otherwise, with the exception of benefits that he has accrued under TCF’s 401(k) Plan, SERP and Deferred Compensation Plan.


- 1 -



3.Releases.

(a)In exchange for the good and valuable consideration set forth herein, Executive agrees for Executive, Executive’s heirs, administrators, representatives, executors, successors and assigns (“Releasors”), to irrevocably and unconditionally release, waive and forever discharge any and all manner of action, causes of action, claims, rights, promises, charges, suits, damages, debts, lawsuits, liabilities, rights, due controversies, charges, complaints, remedies, losses, demands, obligations, costs, expenses, fees (including, without limitation attorneys’ fees), or any and all other liabilities or claims of whatsoever nature, whether arising in contract, tort, or any other theory of action, whether arising in law or in equity, whether known or unknown, choate or inchoate, matured or unmatured, contingent or fixed, liquidated or unliquidated, accrued or unaccrued, asserted or unasserted, including, but not limited to, any claim and/or claim of damages or other relief for tort, breach of contract, personal injury, negligence, and any other claims of unlawful employment practices or any other unlawful criterion or circumstance which Executive and Releasors had, now have, or may have in the future against each or any of TCF, its parent, divisions, affiliates and related companies or entities, regardless of its or their form of business organization, any predecessors, successors, joint ventures, and parents of any Company Entity, and any and all of their respective past or present directors, officers, shareholders, partners, employees, consultants, independent contractors, trustees, administrators, insurers, agents, attorneys, representative and fiduciaries, successors and assigns including without limitation all persons acting by, through, under or in concert with any of them (all collectively, the “Released Parties’) for any act or omission that has occurred up through the date on which Executive signs this Release.

This Release includes but is not limited to any claims arising under Title VII of the Civil Rights Act, 42 U.S.C. § 2000e et seq., the Americans with Disabilities Act, 42 U.S.C. § 12101 et seq., the Age Discrimination in Employment Act of 1967, 29 U.S.C. § 621 et seq., the Older Workers Benefit Protection Act, the Employee Retirement Income Security Act (ERISA), 29 U.S.C. §1001 et seq., the Genetic Information Nondiscrimination Act, 42 U.S.C. § 2000ff et seq., the Civil Rights Act of 1866, 42 U.S.C. § 1981, the Civil Rights Act of 1991, 42 U.S.C. § 1981a, the Equal Pay Act, 29 U.S. C. § 206(d) et seq., the Sarbanes-Oxley Act, 15 U.S.C. § 7201 et seq., the National Labor Relations Act, 29 U.S.C. § 151 et seq., the Worker Adjustment and Retraining Notification Act, 29 U.S.C. §2101 et seq., the Uniformed Services Employment and Reemployment Rights Act of 1994, 38 U.S.C. § 4301 et seq., the Fair Credit Reporting Act, 15 U.S.C. § 1681 et seq., the Minnesota Human Rights Act, Minn. Stat. Chapter 363A, the Minnesota Pregnancy and Parenting Leave Act, Minn. Stat. § 181.940 et seq., the Minnesota Whistleblower Act, Minn. Stat. § 181.931 et seq., Minn. Stat. Chapter 181, Minn. Stat. § 176.82, Minn. Stat. § 204C.04, Minn. Stat. § 593.50, the Minneapolis Civil Rights Ordinance, Title 7, the Minneapolis Sick and Safe Time Ordinance, the St. Paul Earned Sick and Safe Time Ordinance, the. St. Paul Human Rights Ordinance, and any amendments to any of the above, any claims under any other federal, state or local law, rule, ordinance or regulation.
This Release also includes any and all claims against the Released Parties, whether grounded in contract or tort theories, including but not limited to: breach of contract; tortious interference with contractual relations; claims for unpaid compensation (including vacation pay and bonuses); claims for punitive damages or attorneys’ fees; promissory estoppel; detrimental reliance; breach of the implied covenant of good faith and fair dealing; breach of express or implied promise; breach of manuals or other policies; breach of fiduciary duty; assault; battery; fraud; false imprisonment; invasion of privacy; intentional or negligent misrepresentation; defamation, including libel, slander, discharge defamation and self-publication defamation; discharge in violation of public policy; qui tam actions; whistleblower; intentional or negligent infliction of emotional distress; wrongful discharge, and claims under any other theory, whether legal or equitable. Executive understands that Executive does not waive rights or claims based on facts or conditions that may arise after the date on which he signs this Release.

- 2 -



(b)Executive acknowledges that Executive has read this Release carefully and understands all of its terms.

(c)Executive understands and agrees that Executive has been advised to consult with an attorney prior to executing this Release, which he has done.

(d)Executive understands that Executive is entitled to consider this Release for up to twenty-one (21) days before signing the Release. However, after due deliberation, Executive may elect to sign this Release without availing himself of the opportunity to consider its provisions for at least twenty-one (21) days. Executive hereby acknowledges that any decision to shorten the time for considering this Release prior to signing it is voluntary, and such decision is not induced by or through fraud, misrepresentation, or a threat to withdraw or alter the provisions set forth in this Release in the event Executive elected to consider this Release for at least twenty-one (21) days prior to signing the Release.

(e)Executive understands that Executive may revoke this Release as it relates to any potential claim that could be brought or filed under the Age Discrimination in Employment Act 29 U.S.C. §§ 621-634, within seven (7) days after the date on which Executive signs this Release, and that this Release as it relates to such a claim does not become effective until the expiration of the seven (7) day period. Executive is also informed of his right to rescind this Release insofar as it extends to potential claims under the Minnesota Human Rights Act (“MHRA”) by written notice to TCF within fifteen (15) calendar days following Executive’s execution of this Release. The 15-day rescission period shall begin to run on the first calendar day after Executive signs this Release. The 7-day revocation period and 15-day rescission period shall run concurrently. Any such revocation or rescission (“the Revocation”) must be made in writing and delivered by hand or by certified mail, return receipt requested, postmarked on or before the last day within the applicable period to the General Counsel of TCF (with a copy to the Chief Human Resources Officer) at the address provided below.

If Executive exercises his right to revoke or rescind any portion of his release of claims under the ADEA or the MHRA, TCF may, at its option, either nullify this Release in its entirety, or keep it in effect in all respects other than as to that portion of his release of claims that Executive has revoked or rescinded.
(f)In agreeing to sign this Release, Executive is doing so voluntarily and agrees that Executive has not relied on any oral statements or explanations made by TCF or its representatives.

(g)Notwithstanding the above, Executive does not release any rights  with respect to Executive’s rights to be indemnified, if any, in accordance with applicable laws and TCF’s Articles of Incorporation and Bylaws, or under any liability insurance policy carried by the Company for the benefit of its current and past directors, officers and/or employees.

4.Continuing Obligations.

Executive hereby agrees and acknowledges that he is subject to certain continuing obligations pursuant to Section 5 of the Employment Agreement as revised in this Section 4 and the advisory services described in Section 1 above. The “Restricted Period” definition in Section 5(b)(v) of the Employment Agreement is hereby amended to change the Restricted Period duration from 24 months to 36 months; provided, however, that notwithstanding Section 5(c) of the Employment Agreement, (a) Executive may serve on the Board of Directors of any organization effective immediately, and (b) after 24 months following employment termination, Executive may work for any bank or financial institution with assets less than $50 billion. Executive further acknowledges the validity and enforceability of his obligations under Section 5 of the

- 3 -



Employment Agreement, as revised herein and Section 1 above, and agrees that those obligations survive termination of his employment with TCF and shall not be superseded or otherwise negated by this Release.

5.Non-Disparagement.

Executive agrees not to make, cause to be made, issue, release, publish, authorize, or confirm any “Disparaging” (as defined below) remarks, comments, or statements, whether written, oral, or electronic, about TCF, its executives, past and present Bank and Holding Company Board of Directors and the Executive Leadership Team, or its products or services. “Disparaging” remarks, comments, or statements include those that impugn the reputation, goodwill, or legitimate business interests of TCF or its executives, past and present directors, and the Executive Leadership Team.
TCF will instruct its Bank and Holding Company Board of Directors, the Executive Chairman and Executive Leadership Team in place at the time of Executive’s employment termination, to not to make, cause to be made, issue, release, publish, authorize, or confirm any “Disparaging” (as defined below) remarks, comments, or statements, whether written, oral, or electronic, about Executive. “Disparaging” remarks, comments, or statements include those that impugn the reputation of Executive.
The Parties agree and acknowledge that this Section is a substantial, material inducement to the Parties to enter into this Release. It is understood and agreed that this Section is intended to be and shall be construed in such a way as to provide the greatest possible protection for each Party against the other.
6.Cooperation. In addition to the advisory services described herein, Executive agrees to be reasonably available to consult with and cooperate with TCF with regard to matters about which he has institutional knowledge from his period of service with TCF.

7.FMLA & FLSA Compliance. Executive represents and warrants that Executive is not aware of any facts or circumstances that might justify a claim against TCF for any violation of the Family and Medical Leave Act (“FMLA”). Executive represents and warrants, following a deliberate consideration of compensation or benefits to which Employee may be entitled, that Executive has received: (1) any and all legally protected leave to which Executive may have been entitled, including but not limited to leave under the FMLA; and (2) any and all wages, including but not limited to overtime wages, for work Executive performed, as required under the Fair Labor Standard Act (“FLSA”) or comparable state statutes.

8.Code Section 409A. Payments and benefits provided under this Agreement are intended to be exempt from or comply with Code Section 409A, and the provisions of the Agreement are to be construed accordingly. However, in no event shall TCF be responsible for any tax or penalty owed by Executive with regard to payments and benefits provided herein, including any related to Code Section 409A. For purposes of Code Section 409A, each installment of payments or benefits provided hereunder is intended to be treated as a separate payment, and the terms “employment termination” and “termination of employment” or terms of like kind are intended to constitute “separation from service” under Code Section 409A. Notwithstanding any provision in this Agreement to the contrary, if Executive is determined to constitute a “Specified Employee” as defined under Code Section 409A at the time of his employment termination, any payments and benefits provided hereunder that are not then exempt from Code Section 409A shall be aggregated and delayed until the earlier of the first day of the seventh month following Executive’s termination of employment or death, when they shall be paid in the form of a lump sum. Thereafter, any remaining payments and benefits shall be paid as if there had been no earlier delay.


- 4 -



9.Notices. Every notice relating to this Release shall be in writing and if given by mail shall be given by registered or certified mail with return receipt requested. All notices to TCF shall be delivered to TCF’s General Counsel (with a copy to the Chief Human Resources Officer) at the following addresses:

TCF General Counsel: 11100 Wayzata Boulevard, Suite 802, Minnetonka, MN 55305

TCF Chief Human Resources Officer: 2301 W. Big Beaver Road, Suite 525, Troy, MI 48084

Any notice to Executive shall be delivered to Executive personally or addressed to Executive at Executive’s last residence address as then contained in TCF’s records, or such other address as Executive may designate. Either party by notice to the other may designate a different address to which notices shall be addressed. Any notice given by TCF to Executive at Executive’s last designated address shall be effective to bind any other person who shall acquire rights hereunder.
10.Governing Law. This Release shall be governed by and construed in accordance with the laws of the State of Minnesota, without giving effect to conflicts of laws.

11.Counterparts. This Release may be executed in two (2) or more counterparts, all of which when taken together shall be considered one (1), and the same Release and shall become effective when the counterparts have been signed by each Party and delivered to the other Party; it being understood that both Parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) the same.

12.Entire Agreement. This Release, when aggregated with the applicable Sections of the Employment Agreement and equity award agreements, contains the entire understanding of the Parties with respect to the subject matter hereof and together supersedes all prior agreements and understandings, oral or written, with respect to such matters, which the Parties acknowledge have been merged into this Release.

13.    Severability and Judicial Modification. If any portion of the Agreement is adjudicated to be invalid or unenforceable, then a court of competent jurisdiction shall amend, modify or delete that portion thus adjudicated invalid or unenforceable, and the validity and enforceability of the remainder of this Agreement shall be unaffected.
14.    Construction. All words used in the Agreement shall, unless defined herein or in the Employment Agreement, have their plain meaning in ordinary English. The Agreement shall not be construed or interpreted for or against any Party hereto because that Party drafted or caused the Party’s representative to draft any of its provisions. Whenever the context so requires, the singular shall include the plural and vice versa, and the masculine gender shall include the feminine (or neuter) gender and vice versa.
15.    Knowing, Voluntary Agreement. Executive agrees and acknowledges that he has received and read this Agreement, that the provisions of this Agreement are understandable to him, and that he fully appreciates and understands the meaning of its terms and their effect.

- 5 -



IN WITNESS WHEREOF, the parties hereto have executed this Release as set forth below.


Dated:     October 26, 2020              _______________________________________        
Craig R. Dahl, Executive
TCF FINANCIAL CORPORATION

Dated:     October 26, 2020            By:_____________________________________                        
Its: _____________________________________                    






    
TCF FINANCIAL CORPORATION
By:    /s/ Craig R. Dahl
/s/ David T. Provost         Name: Craig R. Dahl
David T. Provost, Executive                Title:    President and Chief Executive Officer







- 6 -



WAIVER OF 21-DAY NOTICE PERIOD
I have been provided with the Release between TCF Financial Corporation (collectively with TCF Bank and all of their affiliates, “TCF”) and Craig R. Dahl (“Executive”).
I understand that I have twenty-one (21) days from the date the Agreement was presented to me to consider whether or not to sign the Agreement. I further understand that I have the right to seek counsel prior to signing the Agreement.
I am knowingly and voluntarily signing and returning the Agreement prior to the expiration of the twenty-one (21)-day consideration period. I understand that I have seven (7) days from signing the Agreement to revoke the Agreement to assert claims under the Age Discrimination in Employment Act and fifteen (15) days from signing the Agreement to revoke the Agreement to assert claims under the Minnesota Human Rights Act, by delivering a written notice of revocation to the General Counsel (with a copy to the Chief Human Resources Officer), TCF Financial Corporation, 11100 Wayzata Boulevard, Minnetonka, MN 55305.


        
Craig R. Dahl, Executive


Dated: ___





Exhibit 99.1

TCFCORPORATELOGO2020.JPG


TCF Press Contact:
Randi Berris (Media)
news@tcfbank.com
(248) 608-5239

Timothy Sedabres (Investors)
investor@tcfbank.com (Investors)
(952) 745-2766


October 26, 2020

TCF Financial Corp. CEO Craig R. Dahl to retire

TCF Executive Chairman Gary Torgow thanks Dahl for guiding the integration of TCF Bank and Chemical Bank
David T. Provost named TCF Financial Corporation chief executive officer
Thomas C. Shafer elevated to TCF National Bank CEO and vice chairman of TCF Financial Corporation
Michael S. Jones named TCF Bank president and chief operating officer

(DETROIT) - TCF Financial Corporation on Monday announced Craig R. Dahl will retire, effective Tuesday, Oct. 27, following the extraordinarily successful integration between TCF Bank and Chemical Bank, a merger Dahl helped lead. The TCF Financial Corporation board of directors elected Vice Chairman David T. Provost as TCF Financial Corporation chief executive officer and elected Thomas C. Shafer to the board of TCF Financial Corporation as vice chairman and CEO of TCF National Bank. Both Shafer and Provost will report to Executive Chairman Gary Torgow.

Michael S. Jones, currently executive vice president, regional banking, will become president and chief operating officer of TCF Bank, reporting to Shafer.

“Craig’s leadership has been instrumental in getting TCF to the point we are today. He has guided TCF through a successful integration program and has worked tirelessly with our teams to build many of our businesses from the ground up over the past 20 years. His passion and dedication have helped to guide the One TCF culture and the strong bench strength of talent we benefit from are a testament to his leadership. We congratulate Craig on a tremendous career and thank him for his many contributions. All of us at TCF are eternally grateful for his leadership,” Torgow said.

Dahl has spent 21 years with TCF and was named president and CEO of legacy TCF in 2016. Upon the merger of equals in 2019, he became president and CEO of TCF.


Page 1 of 2



“I am proud of all of our accomplishments over the past year and the momentum that TCF has today. One of the benefits of our merger of equals is the great talent that rises to the top. These leaders are ready to assume their roles and run the business,” Dahl said. “I would like to extend my appreciation to the Executive Leadership team and Gary for his partnership as we have worked together to integrate the operations and cultures of two banks into One TCF. I am grateful for the opportunities and experiences I’ve had with this great institution.”

Provost served as president and chief executive officer of Chemical Financial Corporation from June 2017 to August 2019, and vice chairman of TCF Financial Corporation since August 2019. Shafer served as vice chairman and a director of Chemical Financial Corporation until August 2019, and has served as president and chief operating officer of TCF Bank since August 2019.

“Dave’s and Tom’s commitment to our team members, customers and communities sets us on a trajectory for monumental success in the years ahead,” Torgow said. “Dave and Tom have worked well together in leading our company since the first days of Talmer Bank, Chemical Bank and through the TCF merger. This is a natural time to implement our succession plan.”

“As a purpose-driven company passionate about building stronger individuals, customers and communities, I am grateful for the opportunity to lead this bank and our dedicated team members. The banking industry is changing dramatically, accelerated by the pandemic, and I am confident that together, we will take TCF to new heights,” Shafer said.

Since the merger, Jones has served as executive vice president of regional banking, responsible for retail banking, consumer lending, small business banking, middle market and regional commercial banking, wealth management, treasury management, municipal banking, mortgages and home lending. Previously, he was executive vice president, consumer banking of legacy TCF, and previously served as its chief financial officer.

“Mike is a wonderful leader and plays a key role in the executive leadership of the bank,” Torgow said.

As previously announced last year, effective Oct. 1, 2020, Brian Maass succeeded Dennis Klaeser as chief financial officer upon his retirement. Maass will report to Shafer. In addition, R. Patricia Kelly, Chris McComish and Daniel W. Terpsma have been elevated to the TCF Bank executive leadership team and will report to Jones.

About TCF: TCF Financial Corporation (NASDAQ: TCF) is a Detroit, Michigan-based financial holding company with $48 billion in total assets at September 30, 2020 and a top 10 deposit market share in the Midwest. TCF’s primary banking subsidiary, TCF National Bank, is a premier Midwest bank offering consumer and commercial banking, trust and wealth management, and specialty leasing and lending products and services to consumers, small businesses and commercial clients. TCF has approximately 475 banking centers primarily located in Michigan, Illinois and Minnesota with additional locations in Colorado, Ohio, South Dakota and Wisconsin. TCF also conducts business across all 50 states and Canada through its specialty lending and leasing businesses. To learn more about TCF, visit tcfbank.com.



Page 2 of 2